Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tuberosum Technologies has achieved a major milestone by registering the first-ever True Potato Seed (TPS) varieties in Canada. These TPS lines offer enhanced disease resistance, improved sustainability, cost-effectiveness, easier storage and transport compared to traditional tuber-based propagation. The registration followed rigorous regulatory review by Canadian authorities. The company's innovations are expected to revolutionize potato cultivation globally by making it more efficient and environmentally friendly.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tuberosum Technologies.